Expression of the Midkine gene in human hepatocellular carcinomas

Hepato-Gastroenterology

Volumn 46, Issue 30, 1999, Pages 3189-3196

  Koide, Norio ^c   Hada, Hajime ^c   Shinji, Toshiyuki ^c   Ujike, Kozo ^c   Hirasaki, Shoji ^c   Yumoto, Yasuhiro ^a   Hanafusa, Tadashi ^a   Kadomatsu, Kenji ^b   Muramatsu, Hisako ^b   Muramatsu, Takashi ^b   Tsuji, Takao ^c  

^a OKAYAMA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

Gene expression; Hepatocellular carcinoma; Liver cirrhosis; Metastatic liver cancer; Midkine

Indexed keywords

MESSENGER RNA; MIDKINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

AGED; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0032763396     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 1 Tickle C, Alberts B, Wolpert L, Lee J: Local application of retinoic acid to the limb bond mimics the action of the polarizing region. Nature 1982; 296:564-566.
2. 2 Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW, Lott IT, Richard JM, Sun SC: Retinoic acid embryopathy. N Engl J Med 1985; 313:837-841.
3. 3 Strickland S, Mahdavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978; 15:393-403.
4. 4 Durston AJ, Timmermans JP, Hage WJ, Hendriks HF, de Vries NJ, Heideveld M, Nieuwkoop PD: Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature 1989; 340:140-144.
5. 5 Kadomatsu K, Tomomura M, Muramatsu T: cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 1988; 151:1312-1318.
6. 6 Muramatsu H, Hamacla H, Noguchi S, Kamada Y, Muramatsu T: Cell-surface changes during in vitro differentiation of pluripotent embryonal carcinoma cells. Dev Biol 1985; 110:284-296.
7. 7 Li Y-S, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodnercm, Milbrandt J, Deuel TF: Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 1990; 250:1690-1694.
8. 8 Merenmies J, Rauvala H: Molecular cloning of 18-kd growth-associated protein of developing brain. J Biol Chem 1990; 265:16721-16724.
9. 9 Muramatsu T: Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol 1993; 37:183-188.
10. 10 Muramatsu H, Muramatsu T: Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem Biophys Res Commun 1991; 177:652-658.
11. 11 Muramatsu H, Shirahama H, Yonezawa S, Maruta H, Muramatsu T: Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol 1993, 159:392-402.
12. 12 Kadomatsu K, Huang R-P, Suganuma T, Murata F, Muramatsu T: A retinoic acid-responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol 1990; 110:607-616.
13. 13 Mitsiadis TA, Salmivirta M, Muramatsu T, Muramatsu H, Rauvala H, Lehtonen E, Thesleff I: Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 1995; 121:37-51.
14. 14 Mitsiadis TA, Muramatsu T, Muramatsu H, Thesleff I: Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. J Cell Biol 1995; 129:267-281.
15. 15 Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, Shimazu H, Ohi Y, Muramatsu T: A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res 1993; 53:1281-1285.
16. 16 Carver RI Jr, Chan CS, Milner PG: Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell Mol Biol 1993; 9:463-466.
17. 17 Carver RI Jr, Radford DM, Donis Keller H, Wick MR, Milner PG: Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 1994; 74:1584-1590.
18. 18 Aridome K, Tsutsui J, Takao S, Kadomatsu K, Masayuki Ozawa, Aikou T, Muramatsu T: Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 1995; 86:655-661.
19. 19 Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Canaan A, Brodeur GM: Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res 1995; 55:1792-1797.
20. 20 O'Brien T, Cranston D, Fuggle S, Bicknell R, and Harris AL: The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res. 1996; 56:2515-2518.
21. 21 Kadomatsu K, Hagihara M, Akhter S, Fan QW, Muramatsu H, Muramatsu T: Midkine induces the transformation of NIH3T3 cells. Br J Cancer 1997; 75:354-359.
22. 22 Adachi Y, Matsubara S, Petraza C, Ozawa M, Tsutsui J, Takamatsu H, Noguchi H, Akiyama T, Muramatsu T: Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). Oncogene 1996; 13:2197-2203.
23. 23 Miyashiro I, Kaname T, Nakayama T, Nakamori S, Yagyu T, Monden T, Kikkawa N, Nishisho I, Muramatsu T, Monden M, Akiyama T: Expression of truncated midkine in human colorectal cancers. Cancer Lett 1996; 106:287-291.
24. 24 Muramatsu H, Song X-J, Koide N, Hada H, Tsuji T, Kadomatsu K, Inui T, Kimura T, Sakakibara S, Muramatsu T: Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas. J Biochem 1996; 119:1171-1175.
25. 25 Song X-J, Muramatsu H, Aridome K, Aikou T, Koide N, Tsuji T, Muramatsu T: The serum level of midkine, a heparin-binding growth factor, as a tumor marker. Biomedical Res 1997; 18: 375-381.
26. 26 Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. 3rd Edition. Kanehara, Tokyo 1992; pp. 1-80.
27. 27 Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
28. 28 Sambrook J, Fritsch EF, Maniatis T: Molecular cloning. A laboratory manual. 2nd Edition. New York: Cold Spring Harbor Laboratory Press, 1989; pp. 7.37-14.21.
29. 29 Tsutsui J-I, Uehara K, Kadomatsu K, Matsubara S, Muramatsu T: A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem Biophys Res Commun 1991; 176:792-797.
30. 30 Nobori T, Minra K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor genes in multiple human cancers. Nature 1994; 368:753-756.